SPECTRIN-LIKE PROTEIN IN DEVELOPING BRAIN
SPECTRIN-LIKE PROTEIN IN DEVELOPING BRAIN
批准号:
3402191
负责人:
IAN S ZAGON
金额:
$15.51万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1992-06-30
关键词:
ankyrins autoradiography binding proteins brain cell brain metabolism cell biology cell differentiation cell migration embryo /fetus erythrocytes eukaryote glia immunochemistry immunocytochemistry immunoelectron microscopy immunofluorescence technique laboratory mouse membrane proteins neurogenesis neurons neuropeptides newborn animals protein structure radiotracer spectrin
中文摘要
该项目旨在探索幽灵蛋白和相关的
细胞骨架蛋白与细胞结构和功能的关系
发育中的神经系统。在这件事的前两年
格兰特我们发现了两种脑影蛋白亚型(240/235)
和(240/235E),并对它们进行了定位
免疫细胞化学和免疫电子技术的异构体
显微镜。脑影蛋白(240/235)主要位于
神经元的轴突和突触前终末。脑部光谱
(240/235E)存在于胞体、树突和突触后
神经元的终末,以及某些类型的神经胶质细胞。这个
这些血影蛋白亚型的个体发育在
免疫放射自显影实验,并与
免疫细胞化学程序。每一种血影蛋白亚型都有一个
在发展中表现和分布的独特模式
神经系统。在本申请中,我们描述了实验
旨在让我们更好地了解大脑
血影蛋白亚型及相关的血影蛋白结合蛋白
关于哺乳动物神经系统的发育。
这项建议的目的是:(1)确定选址和
发育过程中小鼠脑内血影蛋白亚型的分布
用免疫电子显微镜观察脑组织。(2)量化大脑
血影蛋白(240/235E)用免疫斑点定量分析。(3)
定义在同种异构体中是否存在结构变化
在发育过程中使用免疫沉淀和
多肽图谱技术。(4)检查是否有两个
哺乳动物脑内Ankyrin(Syndein)亚型的利用
免疫印迹和免疫组织化学。(5)确定
用免疫印迹法研究脑内锚蛋白亚型的个体发育
免疫斑点、免疫组织化学和免疫电子
显微镜。(6)检测Amelin在大鼠脑内的表达。
使用概述的技术的哺乳动物大脑发育
在(5)中。所提出的研究构成了重要而新颖的内容
血影蛋白样蛋白功能意义的探讨
在神经细胞和组织的结合蛋白中。这
调查是正在进行的蜂窝和
分子神经生物学,试图了解
正常和异常的大脑发育。
英文摘要
This project is designed to explore spectrin and associated
cytoskeletal proteins in regard to the structure and function of
the developing nervous system. During the first 2 years of this
grant we have discovered two subtypes of brain spectrin (240/235)
and (240/235E) in the mammalian brain, and localized these
isoforms with immunocytochemistry and immunoelectron
microscopy. Brain spectrin (240/235) is located primarily in the
axons and presynaptic terminals of neurons. Brain spectrin
(240/235E) is found in the cell bodies, dendrites, and postsynaptic
terminals of neurons, as well as in certain glial cell types. The
ontogeny of these spectrin subtypes was explored in
immunoautoradiography experiments, and closely examined with
immunocytochemical procedures. Each spectrin subtype had a
distinct pattern of expression and distribution in the developing
nervous system. In this application we describe experiments
which are designed to give us a better understanding of brain
spectrin subtypes and associated spectrin binding proteins in
regard to the development of the mammalian nervous system.
The aims of this proposal are: (1) Determine the location and
distribution of brain spectrin subtypes in the developing mouse
brain using immunoelectron microscopy. (2) Quantitate brain
spectrin (240/235E) with quantitative immunodot assay. (3)
Define whether there are structural changes in the isoforms of
spectrin during development using immunoprecipitation and
peptide mapping techniques. (4) Examine whether there are two
ankyrin (syndein) subtypes in the mammalian brain utilizing
immunoblots and immunohistochemistry. (5) Determine the
ontogeny of ankyrin subtypes in the brain with immunoblots,
immunodots, immunohistochemistry, and immunoelectron
microscopy. (6) Examine the expression of amelin during
mammalian brain development employing the techniques outlined
in (5). The studies proposed constitute important and novel
inquiries into the functional significance of spectrin-like proteins
in the binding proteins in neural cells and tissues. This
investigation is part of an ongoing program in cellular and
molecular neurobiology which seeks to understand the process of
normal and abnormal brain development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OGF-OGFr Axis Modulation to Prevent Diabetic Ocular Surface Complications.
-
批准号:10203997
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2018
-
负责人:IAN S ZAGON
-
依托单位:
OGF-OGFr Axis Modulation to Prevent Diabetic Ocular Surface Complications.
-
批准号:9789327
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2018
-
负责人:IAN S ZAGON
-
依托单位:
Naltrexone as a Novel Treatment for Diabetic Keratopathy
-
批准号:7287707
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2004
-
负责人:IAN S ZAGON
-
依托单位:
Naltrexone as a Novel Treatment for Diabetic Keratopathy
-
批准号:6954645
-
项目类别:
-
资助金额:$36.08万
-
财政年份:2004
-
负责人:IAN S ZAGON
-
依托单位:
Naltrexone as a Novel Treatment for Diabetic Keratopathy
-
批准号:6857373
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2004
-
负责人:IAN S ZAGON
-
依托单位:
Naltrexone as a Novel Treatment for Diabetic Keratopathy
-
批准号:7122771
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2004
-
负责人:IAN S ZAGON
-
依托单位:
Naltrexone as a Novel Treatment for Diabetic Keratopathy
-
批准号:8011240
-
项目类别:
-
资助金额:$19.71万
-
财政年份:2004
-
负责人:IAN S ZAGON
-
依托单位:
Gene Gun Technology, Opioids, and Corneal Diseases
-
批准号:6641233
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2001
-
负责人:IAN S ZAGON
-
依托单位:
Gene Gun Technology, Opioids, and Corneal Diseases
-
批准号:6417142
-
项目类别:
-
资助金额:$13.28万
-
财政年份:2001
-
负责人:IAN S ZAGON
-
依托单位:
Gene Gun Technology, Opioids, and Corneal Diseases
-
批准号:6525355
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2001
-
负责人:IAN S ZAGON
-
依托单位:
REGULATION OF CORNEAL WOUND HEALING IN TYPE I DIABETES
-
批准号:6207738
-
项目类别:
-
资助金额:$3.88万
-
财政年份:1999
-
负责人:IAN S ZAGON
-
依托单位:
REGULATION OF CORNEAL WOUND HEALING IN TYPE I DIABETES
-
批准号:6179246
-
项目类别:
-
资助金额:$19.58万
-
财政年份:1999
-
负责人:IAN S ZAGON
-
依托单位:
REGULATION OF CORNEAL WOUND HEALING IN TYPE I DIABETES
-
批准号:6053409
-
项目类别:
-
资助金额:$13.51万
-
财政年份:1999
-
负责人:IAN S ZAGON
-
依托单位:
ENDOGENOUS OPIOID MODULATION OF HUMAN PANCREATIC CANCER
-
批准号:2008793
-
项目类别:
-
资助金额:$18.07万
-
财政年份:1996
-
负责人:IAN S ZAGON
-
依托单位:
CORNEAL WOUND HEALING AND OPIOID GROWTH FACTOR
-
批准号:2872367
-
项目类别:
-
资助金额:$22.23万
-
财政年份:1996
-
负责人:IAN S ZAGON
-
依托单位:
CORNEAL WOUND HEALING AND OPIOID GROWTH FACTOR
-
批准号:2331659
-
项目类别:
-
资助金额:$20.29万
-
财政年份:1996
-
负责人:IAN S ZAGON
-
依托单位:
CORNEAL WOUND HEALING AND OPIOID GROWTH FACTOR
-
批准号:2164066
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1996
-
负责人:IAN S ZAGON
-
依托单位:
ENDOGENOUS OPIOID MODULATION OF HUMAN PANCREATIC CANCER
-
批准号:6124509
-
项目类别:
-
资助金额:$20.38万
-
财政年份:1996
-
负责人:IAN S ZAGON
-
依托单位:
ENDOGENOUS OPIOID MODULATION OF HUMAN PANCREATIC CANCER
-
批准号:2837694
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1996
-
负责人:IAN S ZAGON
-
依托单位:
CORNEAL WOUND HEALING AND OPIOID GROWTH FACTOR
-
批准号:2716454
-
项目类别:
-
资助金额:$21.38万
-
财政年份:1996
-
负责人:IAN S ZAGON
-
依托单位:
海外基金